XML 47 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Revenue (Tables)
9 Months Ended
Sep. 30, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Revenues from Product Lines

  

Three Months

Ended

     

Three Months

Ended

    
  

September 30,

2024

  

Percentage of

Total Revenue

  

September 30,

2023

  

Percentage of

Total Revenue

 
Orthobiologics  $16,579    59%  $15,665    63%
Spinal implant   11,358    41%   9,354    37%
Total revenue  $27,937    100%  $25,019    100%

 

  

Nine Months

Ended

     

Nine Months

Ended

    
  

September 30,

2024

  

Percentage of

Total Revenue

  

September 30,

2023

  

Percentage of

Total Revenue

 
Orthobiologics  $48,123    56%  $43,531    69%
Spinal implant   37,631    44%   19,664    31%
Total revenue  $85,754    100%  $63,195    100%